Enhanced visibility materials for implantation in hard tissue
DCFirst Claim
1. A method of delivering enhanced visibility hard tissue implant material, the implant material including particles for contrast having a size up to about 350μ
- and tracer elements having a size between about 570μ and
about 2200μ
, said method comprising;
flowing an amount of the implant material into a desired implantation site;
viewing, via a medical imaging device, the tracer elements to discern the instantaneous placement of the implant material; and
continuing delivery of the implant material if appropriate initial placement has been achieved.
7 Assignments
Litigations
0 Petitions
Accused Products
Abstract
An enhanced visibility composition for implantation from a remote source, so that the composition can be readily observed under fluoroscopy or other imaging techniques. The compositions include a biocompatible matrix, such as a hard tissue implant material for example, and radiopaque particles mixed in the matrix. The radiopaque particles have a particle size between about 120μ and 2200μ, more preferably about 350μ and 2200μ, even more preferably between about 450μ and 1600μ, and most preferably between about 570μ0 and 1150μ. Preferably the hard tissue implant and the radiopaque particles are formed or prepared in a slurry. Optionally, the enhanced visibility composition may further include additional radiopaque particles or contrast particles mixed in with the composition, which have a particle size between about 120μ and 350μ, preferably between about 120μ and 250μ.
-
Citations
7 Claims
-
1. A method of delivering enhanced visibility hard tissue implant material, the implant material including particles for contrast having a size up to about 350μ
- and tracer elements having a size between about 570μ and
about 2200μ
, said method comprising;flowing an amount of the implant material into a desired implantation site;
viewing, via a medical imaging device, the tracer elements to discern the instantaneous placement of the implant material; and
continuing delivery of the implant material if appropriate initial placement has been achieved. - View Dependent Claims (2, 3, 4, 5, 6, 7)
- and tracer elements having a size between about 570μ and
Specification